VONTOBEL ASSET MANAGEMENT INC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 85 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2018. The put-call ratio across all filers is 3.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
VONTOBEL ASSET MANAGEMENT INC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2018$13,875,000
-80.6%
139,683
-84.0%
0.10%
-79.9%
Q1 2018$71,525,000
+933.6%
873,968
+894.9%
0.51%
+946.9%
Q4 2017$6,920,000
+31.7%
87,846
+54.3%
0.05%
+28.9%
Q3 2017$5,255,00056,9280.04%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2018
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders